114 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
Adverse Effect.
(q) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
6-K
EX-5.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
beyond the matters expressly so stated. This opinion letter is given as of the date hereof and we do not undertake any liability or responsibility
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
responsibility for the payment or notice even if that holder is required, under agreements with depositary participants or customers or by law, to pass … in a global security. We and the trustee have no responsibility for any aspect of the depositary’s actions or for its records of ownership interests
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
to that collaboration could be delayed or terminated, or it may be necessary for us to assume responsibility for expenses or activities that would otherwise have … been the responsibility of our collaborator. If we are unable to establish and maintain collaborative relationships on acceptable terms
F-3
4s9qqkqqs4nn9t0eou
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
lhp t43tu
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
01s3qflt
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
duwkv23o052523j48d
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
uby9jkzl
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
nv0pwtus
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-5.2
1zn 7l59uo3h
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
901y213rew2m1nfpt
21 Sep 22
Current report (foreign)
8:00am
424B5
w6bfu5pomdir5
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
fi8qp pid700sl9k9y
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
aggthj6 yyb
3 Sep 21
Current report (foreign)
4:30pm
424B5
kvhxsmuy x1vol
3 Sep 21
Prospectus supplement for primary offering
4:29pm